FTC/TDF
Key Takeaways for PrEP, HIV Treatment and Other Infectious Diseases
CROI 2025 highlighted promising therapeutic modalities for HIV treatment and prevention.
JULY 9, 2025
FDA Approves Expanded Indication for Truvada for PrEP for Adolescents
In the United States, adolescents and young adults aged 13 to 24 years comprised 21% of all new infections in 2016, ...
JULY 2, 2018
FDA Expands Indication for Truvada for PrEP Among Adolescents
The FDA granted a new indication for Gilead's Truvada to reduce the risk for sexually acquired HIV-1 in at-risk ...
MAY 15, 2018
Load more